J. E. Davis - 23 Feb 2022 Form 4 Insider Report for QUEST DIAGNOSTICS INC (DGX)

Signature
/s/ William J. O'Shaughnessy, Jr., attorney-in-fact for James E. Davis
Issuer symbol
DGX
Transactions as of
23 Feb 2022
Net transactions value
-$317,001
Form type
4
Filing time
25 Feb 2022, 18:03:42 UTC
Next filing
28 Feb 2022

Key filing fact

J. E. Davis filed Form 4 for QUEST DIAGNOSTICS INC (DGX) on 25 Feb 2022.

Key facts

  • This page summarizes J. E. Davis's Form 4 filing for QUEST DIAGNOSTICS INC (DGX).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Filing timestamp: 25 Feb 2022, 18:03.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: -$317,001.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Transactions Table

DGX transaction

Common Stock

Tax liability

Transaction value
$222,714
Shares
-1,712
Change %
-3.4%
Price
$130.09
Shares after
48,219
Date
23 Feb 2022
Ownership
Direct
Footnotes
F1
DGX transaction

Common Stock

Tax liability

Transaction value
$94,287
Shares
-724
Change %
-1.5%
Price
$130.23
Shares after
47,495
Date
23 Feb 2022
Ownership
Direct
Footnotes
F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted share units.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .